Live feed08:00:00·1hPRReleasevia QuantisnowUroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder CancerByQuantisnow·Wall Street's wire, on your screen.URGN· UroGen Pharma Ltd.Health Care
